Cannabis year-in-review: 22 takeaways from 2022

By |2022-12-28T03:27:46+00:0028 December 2022|

This year saw some exciting developments for cannabis across Europe, but the UK’s medical cannabis system must do more to support patients.  In 2022 new research showed promising potential for cannabis to treat pain, depression, Covid-19 and even Alzheimer’s; Germany announced plans to legalise adult-use cannabis; [...]

Comments Off on Cannabis year-in-review: 22 takeaways from 2022

Cannabis can reduce liver damage caused by alcohol – study

By |2022-12-24T03:26:33+00:0024 December 2022|

Could cannabis help mitigate some of the liver damage caused by excessive alcohol consumption? A recent study suggests so.   Cannabis is often touted as a less harmful alternative to alcohol. However, a new study has found that the compounds found in the plant may actually reduce [...]

Comments Off on Cannabis can reduce liver damage caused by alcohol – study

Cole’s ‘Christmas wish’ for year’s supply of cannabis oil comes true

By |2022-12-23T03:05:39+00:0023 December 2022|

A Scottish mum says she has been ‘blown away’ by the support of donors who helped raise £18,000 to fund her son’s medication for a year.  Thirty six business owners in Lanarkshire, Scotland have pledged £500 to help cover the costs of medical cannabis treatment for [...]

Comments Off on Cole’s ‘Christmas wish’ for year’s supply of cannabis oil comes true

Zerenia Clinics celebrates first year of operation in the UK

By |2022-12-22T03:33:31+00:0022 December 2022|

Zerenia Clinics UK recently marked its first anniversary, having helped over 500 patients to access potentially life-changing cannabis medicine. At the end of November, Zerenia Clinics UK celebrated its first year of operation in the UK.  In its initial year, Zerenia Clinics UK is proud to [...]

Comments Off on Zerenia Clinics celebrates first year of operation in the UK

Government review to explore barriers to research on controlled drugs

By |2022-12-22T03:33:25+00:0022 December 2022|

The UK government has called for a review to address some of the barriers currently holding back research into controlled drugs, including synthetic cannabinoids.  Home Office officials have acknowledged that the current regulations may be holding back research into Schedule 1 drugs, including synthetic cannabinoids (SCRAs). [...]

Comments Off on Government review to explore barriers to research on controlled drugs

2022 Cannabis Labs Virtual Conference: December Program

By |2022-12-22T03:33:21+00:0022 December 2022|

2022 Cannabis Labs Virtual Conference: December Program Sponsored by Avivatech & Millipore Sigma Click here to watch the recording Agenda Potency Inflation: The Problem, the Causes and the Solutions Sarah Otis, Quality, R&D Manager, Anresco Laboratories Erik Paulson, Ph.D., Lab Manager, InfiniteCAL THC potency inflation by [...]

Comments Off on 2022 Cannabis Labs Virtual Conference: December Program

Cannabis decriminalisation doesn’t increase road traffic accidents, finds study

By |2022-12-21T03:36:18+00:0021 December 2022|

Cannabis decriminalisation is not associated with a notable increase in traffic accidents, finds a new report. The report from the Canadian Institute of Actuaries (CIA) and the Casualty Actuarial Society (CAS) analyses the impact of cannabis decriminalisation on the vehicular accident experience in Canada and the [...]

Comments Off on Cannabis decriminalisation doesn’t increase road traffic accidents, finds study

500 experts urge Home Office to take ‘public health approach’ to drugs

By |2022-12-21T03:36:09+00:0021 December 2022|

An open letter urging the UK government to reconsider its proposals for harsher drug penalties, has been signed by 500 public health and criminal justice experts.  Leading public bodies including the Faculty of Public Health, Police Foundation and the British Medical Association, have expressed ‘serious concerns’ [...]

Comments Off on 500 experts urge Home Office to take ‘public health approach’ to drugs

Five tips to tackle cost-of-living stress this Christmas

By |2022-12-20T03:20:35+00:0020 December 2022|

If internet searchers are anything to go by, Brits are feeling pretty frazzled right now. Experts at Simply CBD share some stress-busting tips to encourage calm and relaxation this season. The lingering stress of the cost-of-living crisis weighs heavily on the shoulders of many, and with [...]

Comments Off on Five tips to tackle cost-of-living stress this Christmas

Medical cannabis access linked to reduced alcohol sales – study

By |2022-12-20T03:20:15+00:0020 December 2022|

Access to medical cannabis is associated with a reduction in alcohol sales, a new Canadian study has found. The data, published in the journal Health Policy, shows that the legalisation of medical cannabis in Canada was associated with a reduction in alcohol sales, suggesting it may [...]

Comments Off on Medical cannabis access linked to reduced alcohol sales – study

Cantourage Clinic rated ‘good’ following CQC inspection

By |2022-12-17T03:11:33+00:0017 December 2022|

Cantourage Clinic, which prescribes cannabis to patients across the UK, has received high praise from the Care Quality Commission following a recent inspection. Following an inspection by the CQC in October, Cantourage Clinic has been rated as ‘Good’ by the independent regulator. The report published detailed [...]

Comments Off on Cantourage Clinic rated ‘good’ following CQC inspection

Could a new technology improve the absorption and efficacy of CBD?

By |2022-12-17T03:11:20+00:0017 December 2022|

A biotech startup based in Poland is working on a technology which it claims could revolutionise the way CBD products are absorbed. Low absorption of CBD products in the body is a concern for manufacturers and consumers alike, as the level of absorption ultimately determines the [...]

Comments Off on Could a new technology improve the absorption and efficacy of CBD?

Revealed: ‘major disconnect’ between NHS and private cannabis prescribing

By |2022-12-17T03:11:09+00:0017 December 2022|

New information reveals a ‘major disconnect’ between NHS and private prescribing of cannabis medicines is ‘holding back progress’ in the UK, potentially failing thousands of patients. More than six in 10 NHS Foundation Trusts in England (61%) say they did not prescribe any cannabis-based medicines in [...]

Comments Off on Revealed: ‘major disconnect’ between NHS and private cannabis prescribing

Malta’s legal cannabis clubs could provide relief for struggling patients

By |2022-12-16T03:27:42+00:0016 December 2022|

Malta legalised medical cannabis in 2018, but according to advocates the ecosystem is prohibitive and focused on industry profit over patient welfare. Could soon-to-open legal cannabis social clubs provide a trusted alternative? Malta made waves in 2021 when it became the first EU country to legalise [...]

Comments Off on Malta’s legal cannabis clubs could provide relief for struggling patients

New UK data holds hope for cannabis and PTSD

By |2022-12-15T03:02:58+00:0015 December 2022|

Real-world data from the UK shows patients with post-traumatic stress disorder (PTSD) experienced an improvement in symptoms and quality of life when prescribed cannabis.  The new study published in the Expert Review of Neurotherapeutics found that patients enrolled on the UK Medical Cannabis Registry experienced an [...]

Comments Off on New UK data holds hope for cannabis and PTSD

Minor cannabinoids to be studied as part of NIH epilepsy programme

By |2022-12-15T03:02:42+00:0015 December 2022|

A Canadian cannabis company is set to study minor cannabinoids for the treatment of epilepsy as part of a National Institute of Health (NIH) programme. Cannabis research company, Cannabis Orchards, has signed an agreement with the National Institute of Health (NIH) to participate in the Epilepsy [...]

Comments Off on Minor cannabinoids to be studied as part of NIH epilepsy programme

What are intoxicating hemp-derived cannabinoids (IHDCs), and are they safe?

By |2022-12-15T03:02:18+00:0015 December 2022|

Demand for intoxicating hemp-derived cannabinoids (IHDCs) – which give users a legal ‘high’ – is now rising across Europe and the UK, but a lack of research and regulation could put consumers at risk.  CBD could be considered the calming, non-psychoactive cousin of delta-9 THC, the [...]

Comments Off on What are intoxicating hemp-derived cannabinoids (IHDCs), and are they safe?

Catching up with Jushi Creativity: A Q&A with Dre Neumann

By |2022-12-15T03:02:11+00:0015 December 2022|

Jushi Holdings is a large multi-state operator with a massive national footprint and a presence in key markets, including Pennsylvania, Illinois, Virginia, Massachusetts, Nevada, Ohio and California.  About a year and a half ago, Aaron Green interviewed Andreas “Dre” Neumann, Chief Creative Director of Jushi Holdings [...]

Comments Off on Catching up with Jushi Creativity: A Q&A with Dre Neumann

OPINION: Five-year sentence for Ireland cannabis caregiver is ‘brutal’ and ‘wildly disproportionate’

By |2022-12-14T03:22:36+00:0014 December 2022|

Earlier this month Irish dad-of-two, Patrick Moore, was sentenced to five years for the cultivation and supply of cannabis, much of which was donated to severely ill patients. The tragic consequences will be felt by many, writes friend and long-time activist, Peter Reynolds. Patrick Moore lives [...]

Comments Off on OPINION: Five-year sentence for Ireland cannabis caregiver is ‘brutal’ and ‘wildly disproportionate’

Switzerland’s ‘Weed Care’ trial of adult-use cannabis to launch January 2023

By |2022-12-14T03:22:14+00:0014 December 2022|

Europe’s first trial of adult-use THC cannabis is expected to begin in the new year, Swiss officials have confirmed.  Switzerland’s so-called ‘Weed Care’ trial, the first pilot program to study the effects of adult-use cannabis legalisation in Europe, is set to launch at the end of [...]

Comments Off on Switzerland’s ‘Weed Care’ trial of adult-use cannabis to launch January 2023

The 3-Legged Stool of Successful Grow Operations: Climate, Cultivation & Genetics – Part 5

By |2022-12-14T03:22:05+00:0014 December 2022|

This is Part 5 in The 3-Legged Stool of Successful Grow Operations series. Click here to see Part 1, here to see Part 2,  here to see Part 3, and here to see part 4. Stay tuned for the final piece in the series, Part 6, coming in the new [...]

Comments Off on The 3-Legged Stool of Successful Grow Operations: Climate, Cultivation & Genetics – Part 5

New research holds promise for cannabis as treatment for Tourette’s syndrome

By |2022-12-13T03:11:05+00:0013 December 2022|

New research has found significant improvements in quality of life among Tourette’s patients’ consuming cannabis-based products. Cannabis products are associated with improved quality of life and a reduction in prescription medications among patients with Tourette syndrome, new research shows. Tourette’s syndrome is a neurological disorder, which [...]

Comments Off on New research holds promise for cannabis as treatment for Tourette’s syndrome

Number of legal cannabis patients in Europe grew by approximately 100,000 in 2022

By |2022-12-13T03:10:48+00:0013 December 2022|

The number of medical cannabis patients in Europe grew by almost 100,000 over the last year, according to new data, but access remains out of reach for many. The majority of people in Europe now live in countries with some form of access to medical cannabis [...]

Comments Off on Number of legal cannabis patients in Europe grew by approximately 100,000 in 2022

Charity steps in to support six-year-old whose access to medical cannabis is under threat

By |2022-12-10T03:09:25+00:0010 December 2022|

A charity set up to help fund the cost of children’s medical cannabis prescriptions has stepped in to support a family who face losing access to their son’s oil. The family of six-year-old Oliver Rice, who has treatment-resistant epilepsy, has received a three-month financial grant from [...]

Comments Off on Charity steps in to support six-year-old whose access to medical cannabis is under threat

First Pharma vs Cannabis Clinical Trial Moves Forward

By |2022-12-10T03:09:19+00:0010 December 2022|

Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, and Affinity Bio Partners, [...]

Comments Off on First Pharma vs Cannabis Clinical Trial Moves Forward

New research hopes to shine a light on benefits of CBD for people and pets

By |2022-12-09T03:06:42+00:009 December 2022|

CBD startup, Hemp Heros, is partnering with University College Dublin (UCD), medical professionals and veterinarians, to expand research on full-spectrum CBD for people and their pets. The UK’s CBD revolution is in full swing. CBD-based supplements are an increasingly common sight in cupboards across the country [...]

Comments Off on New research hopes to shine a light on benefits of CBD for people and pets

Historic US cannabis research bill sparks calls for change in the UK

By |2022-12-09T03:06:20+00:009 December 2022|

Industry leaders hope the passing of a landmark bill to expand cannabis research in the US will encourage the UK government to recognise its potential. Following the passing of historical new legislation in the US, cannabis industry leaders have called for the UK government to recognise [...]

Comments Off on Historic US cannabis research bill sparks calls for change in the UK

Deliveroo makes official complaint against cannabis seller Dispenseroo

By |2022-12-08T03:07:46+00:008 December 2022|

The online food giant, Deliveroo, is taking action against an illegal cannabis seller over ‘obvious mimicking’ of its brand. The digital takeaway delivery service, Deliveroo, has confirmed that it is taking official action against an illicit cannabis start-up which appears to mimic the company’s branding.  Dispenseroo, [...]

Comments Off on Deliveroo makes official complaint against cannabis seller Dispenseroo

Up to a third of UK children receiving end-of-life care may be using cannabis

By |2022-12-08T03:07:34+00:008 December 2022|

Many UK families are accessing cannabis for children with cancer and other life-limiting illnesses, say experts, without any support from their doctors. Despite cannabis not being prescribed for childhood cancer, even through private clinics, many families in the UK are thought to be accessing it illicitly [...]

Comments Off on Up to a third of UK children receiving end-of-life care may be using cannabis

The 3-Legged Stool of Successful Grow Operations: Climate, Cultivation & Genetics – Part 4

By |2022-12-08T03:07:25+00:008 December 2022|

This is Part 4 in The 3-Legged Stool of Successful Grow Operations series. Click here to see Part 1, here to see Part 2, and here to see Part 3. Stay tuned for Part 5, coming next week. Integrated Pest Management (IPM) Aeroponic & hydroponic systems can operate [...]

Comments Off on The 3-Legged Stool of Successful Grow Operations: Climate, Cultivation & Genetics – Part 4

Are teens ditching alcohol for cannabis? Study reveals major shifts in substance use

By |2022-12-07T03:07:10+00:007 December 2022|

A 20-year US study points to major shifts in teenage substance use trends, with alcohol abuse declining while the consumption of cannabis edibles climbs. Adolescent cannabis abuse has increased 245% since 2000 in the US, according to a new study, while alcohol abuse has steadily declined [...]

Comments Off on Are teens ditching alcohol for cannabis? Study reveals major shifts in substance use

What does a legal cannabis market in Germany mean for medical access?

By |2022-12-07T03:06:51+00:007 December 2022|

Germany is likely to legalise the adult-use of recreational cannabis in 2024, but what does this mean for the country’s medical cannabis community?  Cannabis is not a dirty secret in Germany. Tens of thousands of patients—potentially more than 1% of the population—benefit from medical access, with [...]

Comments Off on What does a legal cannabis market in Germany mean for medical access?

2022 Cannabis Supply Chain Virtual Conference

By |2022-12-07T03:06:48+00:007 December 2022|

2022 Cannabis Supply Chain Virtual Conference Sponsored by CannaSpyGlass View On-Demand Now Click here to see all available CIJ events and webinars Agenda A Smarter Cannabis Beverage Distribution Model Jason Vegotsky, Chief Executive Officer, Petalfast Current cannabis distribution models make it hard for emerging cannabis beverage [...]

Comments Off on 2022 Cannabis Supply Chain Virtual Conference

Medical cannabis legalisation linked to reduction in opioid use among cancer patients – study

By |2022-12-06T03:13:20+00:006 December 2022|

Cancer patients used less opioids to manage their pain while receiving treatment in states where medical cannabis was legalised, according to a new study. The findings of the study suggest that medical cannabis legalisation was associated with a lower rate of opioid dispensing and pain-related hospital [...]

Comments Off on Medical cannabis legalisation linked to reduction in opioid use among cancer patients – study

Officials advise ‘patience’ as cannabis dispensing service launches on Isle of Man

By |2022-12-06T03:13:15+00:006 December 2022|

Patients from the Isle of Man can now have their cannabis prescriptions fulfilled locally after several months of delays. As of Thursday 1 December, patients with a private prescription for Cannabis Based Products for Medicinal use (CBPMs) are able to have their prescription fulfilled on the [...]

Comments Off on Officials advise ‘patience’ as cannabis dispensing service launches on Isle of Man

“We know what patients want and can meet their expectations,” says AltoVerde founder

By |2022-12-06T03:13:00+00:006 December 2022|

In a market which some would argue is not sufficiently meeting the needs of patients, European cannabis producer AltoVerde aims to bring quality and transparency to the sector.  Questionable quality, inconsistent supply and a lack of detailed product information. The team at AltoVerde has identified some [...]

Comments Off on “We know what patients want and can meet their expectations,” says AltoVerde founder

New report reveals why many UK doctors are not prescribing medical cannabis

By |2022-12-03T03:04:03+00:003 December 2022|

A new report gives an insight into the multitude of challenges preventing more UK clinicians from prescribing cannabis medicines. Cannabis must be treated the same as any other medication if we want to see mainstream prescribing in the UK, say doctors in a landmark report out [...]

Comments Off on New report reveals why many UK doctors are not prescribing medical cannabis

Avida Global to manufacture medical cannabis products in the UK

By |2022-12-02T07:10:39+00:002 December 2022|

The company plans to manufacture and distribute medicinal cannabis products in the UK following the recent acquisition of BCM Specials. Avida Global has announced the acquisition of Nottingham based, BCM Specials Ltd, the longest established Specials manufacturer in the UK. The new company, Avida Medical, will [...]

Comments Off on Avida Global to manufacture medical cannabis products in the UK

New CBD candidate said to boost bioavailability, expanding therapeutic potential

By |2022-12-02T07:10:28+00:002 December 2022|

A new drug candidate is said to have demonstrated a three to fourfold increase in bioavailability when compared to unmodified CBD. A clinical-stage biotherapeutics company, PureTech Health, says its oral CBD candidate could expand the therapeutic application of the cannabinoid as a treatment for a range [...]

Comments Off on New CBD candidate said to boost bioavailability, expanding therapeutic potential

MHRA’s New Guidance Points To A ‘Truly Pharmaceutical Path’ For UK Medical Cannabis And Could See End To ‘GACP To GMP Washing’

By |2022-12-01T03:16:57+00:001 December 2022|

THE UK’s Medicines and Healthcare products Regulatory Agency (MHRA) last week released new detailed guidelines for medical cannabis companies operating in the UK.  This new guidance from the MHRA and the Home Office sought, for the first time, to provide a step-by-step plan for companies ‘that [...]

Comments Off on MHRA’s New Guidance Points To A ‘Truly Pharmaceutical Path’ For UK Medical Cannabis And Could See End To ‘GACP To GMP Washing’

OPINION: ‘As a recovering alcoholic, cannabis has helped me immensely’

By |2022-12-01T03:16:48+00:001 December 2022|

Cannabis can help us see the beauty in every day, writes Casper James* who says the plant has helped him recover from alcohol addiction and embrace his creativity. I am a recovering alcoholic and have found cannabis to be a huge help in my recovery.  Some [...]

Comments Off on OPINION: ‘As a recovering alcoholic, cannabis has helped me immensely’

Jazz Pharma to present new research findings on Epidyolex

By |2022-12-01T03:16:38+00:001 December 2022|

The company behind the cannabis-based treatment, Epidyolex, has shared new findings on its role in treating seizures related to rare forms of epilepsy. Jazz Pharmaceuticals will share new research on its CBD-based drug, Epidyolex/Epidiolex at the upcoming American Epilepsy Society (AES) annual meeting from 2-6 December [...]

Comments Off on Jazz Pharma to present new research findings on Epidyolex

No Green Wave This Time, But Two More States Legalize Adult Use Cannabis

By |2022-12-01T03:16:35+00:001 December 2022|

Five states voted on adult-use cannabis legalization. These results increase the number of states that have legalized cannabis for adult-use from 19 to 21. Similar ballot measures failed, however, in Arkansas, North Dakota and South Dakota. The continued expansion of legalized cannabis at the state level, [...]

Comments Off on No Green Wave This Time, But Two More States Legalize Adult Use Cannabis

Challenges Abound for Cannabis Industry Growth in 2023

By |2022-12-01T03:16:29+00:001 December 2022|

With an adverse regulatory environment, labor shortages, supply chain disruptions and the always-present threat of property damage and product recalls, cannabis operators are fighting an uphill battle to stay viable in today’s environment. According to Politico, more than 20 of the largest publicly-traded cannabis companies lost about [...]

Comments Off on Challenges Abound for Cannabis Industry Growth in 2023